Researchers@EVMS
Toggle navigation
Browse
Home
People
Departments
Research Areas
Capability Map
Publications
Events
Clinical Trials
Student Opportunities
FAQ
PNEUMOLOGIE
Journal
Overview
Identity
View All
Overview
publication venue for
Efficacy of tezepelumab in adults with severe, uncontrolled chronic rhinosinusitis with nasal polyps as part of Samter's triad (WAYPOINT)
2026
Tezepelumab reduced inflammatory biomarkers in adults with severe chronic rhinosinusitis with nasal polyps with or without asthma: results from the Phase 3 WAYPOINT study
2026
Add-on mepolizumab for chronic rhinosinusitis with nasal polyps: SYNAPSE study
2021
Identity
International Standard Serial Number (ISSN)
0934-8387
Electronic International Standard Serial Number (EISSN)
1438-8790
